Glycopyrrolate Inhalation Solution (GIS) with eFlow Nebulizer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycopyrrolate Inhalation Solution (GIS) with eFlow Nebulizer, covering 2018-04-30 to 2018-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]